Laugh First, Think Later: IG Nobel Prizes Entertain
What did the productive procrastinator say to the beetle on the beer bottle? “Oh, you won an Ig Nobel Prize, too!”
BioWorld’s Fourth Quarter Biotech Calendar
BioWorld doesn’t have an editorial calendar outlining our planned coverage, because so much of what we write depends on breaking news. That said, here’s a sneak peek at the stories most likely to end up on our cover before the…
Kudos to Four Little Biotechs Doing Cool Science
I recognize that while a lot of you busy biotech folk subscribe to BioWorld Today, I am probably one of the only people who actually reads every single word of the paper every single day.
A Little Bit of Certainty Could Go a Long Way
Regulatory certainty. It’s something industry needs and investors want to see. It’s also one of the drivers for job creation. But it’s something our government doesn’t seem to get.
Michele Bachmann Endangered Women’s Lives
Teary-eyed mother to Michele Bachmann: Michele, my daughter took the HPV vaccine and spontaneously became mentally retarded.
Will Dendreon’s Slide Force Cancer Vaccines Out of Style?
Back in 2008, biotech companies working on cancer vaccines were not exactly shouting it from the rooftops. In fact, most companies working in the space quietly began branding their drug candidates “immunotherapies” when they met with investors in an attempt…
The Biogodess: Chief Executive of Biotech Industry Nurturing
She’s best known as the Biogodess. A biotech insider who can recount the early days in the sector — when the industry was first starting to attract serious biobucks. The Biogodess has helped many bridge the gap of knowledge between…
How to Pitch BioWorld: Five More Tips
If you read our post earlier this week (Top 5 Tips for Pitching BioWorld), you know what kind of news BioWorld Today covers. Here are five more helpful hints regarding how to work with us:
Unless it’s Affordable, Curing Cancer is Just a Dream
Although they’re the stuff of science, statistics too often lack the power to move us. After all, they’re just numbers. So when companies like Dendreon Corp. and Seattle Genetics Inc. price their cancer treatments at nearly $100,000 or more, we…
Top 5 Tips for Pitching BioWorld
After six years in biotech PR and five years as a biotech journalist, I have both written and received a heckuva lot of pitches. I know how hard media pitching can be, and I always try to take the time…
Join the Conversation